BioLean® System

Omega-3 - Clinical trials - Mental health

   Chalon, S., S. Delion-Vancassel, et al. (1998)

"Dietary fish oil affects monoaminergic neurotransmission and behavior in rats." J Nutr 128: 2512-2519.


   Gesch cb et al. (2002)

Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. University Laboratory of Physiology, University of Oxford, UK.


   Gump BB; MRFIT Research Group (2005)

"Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial." Stroke. 2005 Jan;36(1):98-102. Epub 2004 Nov 29.


   Horrobin, D. (2002)

A New Category Of Psychotropic Drugs Bioactive Lipids As Exemplified By Ethyl Eicosapentaenoate (E-E). Progress in Drug Research. E. Zucker. Basel, Berghauser Verlag: 171-199.


   Marangell LB et al. (2003)

A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. Mood Disorders Center, Department of Psychiatry, Baylor College of Medicine, Suite 560, 6655 Travis Road, Houston, TX 77030, USA. laurenm@bcm.tmc.edu


   Marangell, L., J. Martinez, et al. (2003)

"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression." American Journal of Psychiatry 160: 996-998.


   Nemets, B., Z. Stahl, et al. (2002)
"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder." American Journal of Psychiatry


   Peet, M. and D. Horrobin (2002)

"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs." Archives of General Psychiatry 59: 913-919.


   Stoll, A. L., W. E. Severus, et al. (1999)

"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial." Archives of General Psychiatry 56 : 407-412.


   Su kp and al. (2003)

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Su KP, Huang SY, Chiu CC, Shen WW. Department of Psychiatry, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan. cobol@www.cmch.org.tw


   Zanarini, M. and F. Frankenburg (2003)
"Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study."
American Journal of Psychiatry 160 (1): 167-169


back to top


  • Marine omega-3 Fatty Acids for treatment of mental depression
    -- read

  • Effects of omega-3 fatty acids on mental health
    -- read

  • Studies show fish oil may preserve thinking ability in elderly
    -- read

  • Omega-3 fatty acids and depression
    -- read

  • Fish Fights Aging in the Brain
    -- read

  • Omega-3 fatty acids and migraine
    -- read

  • 3 new articles on omega-3
    -- read

  • Omega-3 and mental depression
    -- read


  • Effects of DHA on the prevention of Alzheimer's disease
    -- read

  • Study shows omega-3 fatty acids prevent memory decline in alzheimer's disease patients
    -- read

  • Omega-3 and Alzheimer's Dementia
    -- read

  • Mental Health Research
    -- read





WINOmeg3complexTM | Understanding Omega-3 | Are you getting enough? | FAQ
Heart | Brain | Joints | Vision | Children & Pregnancy | Other Health Issues

© 2005-2008 by Wellness International Network, Ltd. All rights reserved.

The information contained herein has not, to WIN’s knowledge, been evaluated by the Food and Drug Administration. WIN does not sell or market its products with intent to diagnose, treat, cure, mitigate or prevent any specific disease or class of diseases.